Navin Fluorine Share Price

Mumbai-headquartered Navin Fluorine International Ltd, a part of the Padmanabh Mafatlal Group, is a leading speciality chemicals company. It has business operations in India and the United Kingdom.

The company offers refrigerants to original equipment manufacturers (OEMs), service technicians, and equipment owners. The company offers its refrigerant products under the Mafron brand.

It also provides inorganic fluoride products comprising ammonium bifluoride, potassium fluoride, sodium fluoride, potassium fluorotitanate, potassium fluoroborate and hexafluorophosphoric acid.

Set up in 1967, NFIL introduced refrigerants into India by commissioning its manufacturing plant at Surat, The unit started commercial production of refrigerant gases in 1969. Incorporated on June 25, 1998, the company manufactures speciality fluorochemicals.

NFIL’s R&D unit Navin Research Innovation Centre (NRIC) was established in Gujarat’s Surat in 2008.

The company churns out over 60 fluorinated products for domestic and international customers. It exports over 40% of its products to North America, Europe, Middle East and Asia Pacific regions.

In FY23, the company earned 66% of its revenue from exports.

The company’s fast expanding catalogue now features over 40,000 compounds, many of which are produced in its laboratories.

It was listed in the bourses on September 30, 2003. The market capitalisation of Navin Fluorine International stood at over ₹17,000 crore as of January 21, 2024. Navin Fluorine share price has surged more than 36% in the last three years.

Navin Fluorine International Ltd business operations

NFIL has four main strategic business units - refrigeration gases, inorganic fluorides, speciality fluorides and contract development and manufacturing.

It owns and operates manufacturing plants at Surat and Dahej in Gujarat and Dewas in Madhya Pradesh.

The company’s unit at Surat specialises in producing refrigerants, various organic and inorganic fluorides. The site handles and processes multiple complex chemistries at various scales of operations. It churns out key products like anhydrous hydrofluoric acid, R-22 and boron trifluoride.

The contract research services arm develops process chemistries, novel analogues, and derivatives around the customers’ target molecules to support research and discovery activities.

NFIL’s UK-based subsidiary Manchester Organics Limited takes part in this early discovery phase with the innovator customers.

NFIL offers contract development and manufacturing facilities for custom chemical syntheses of fluorinated compounds for pharmaceuticals, agriculture and speciality chemicals industries.

The company’s cGMP pilot plant facility at Dewas enables it to supply specialised and niche fluorinated molecules derived from milligram to multi-kilogram level quantities.

NFIL’s customer base includes leading life sciences, crop protection, petrochemical and speciality chemical companies, several of them belonging to the Fortune 500 category.

The company is further investing to bolster its manufacturing capabilities by building a world-class cGMP multi-purpose plant to cater to the multi-ton requirements of customers.

Financial highlights

The company’s consolidated revenue from operations grew 43% to ₹2,077.40 crore in FY23, from ₹1,453.36 crore in FY22. The company’s consolidated net profit (profit after tax) stood at ₹375.18 crore for FY23, up 43% from ₹263.07 crore in FY22. The company’s EBITDA margins stood at 26% in FY23. Its consolidated earnings before interest, tax, depreciation and amortisation (EBITDA), increased to ₹586.04 crore in FY23 compared to ₹394.03 crore in FY22. The company's earnings per share (EPS) increased to ₹75.70 in FY23 as against ₹53.12 in FY22.